Evidence map›Paper›PMID 29720037›Full record

Trial reportJournal of clinical and experimental neuropsychology2018

Brain's compensatory response to drug-induced cognitive impairment.

Immanuel Babu Henry Samuel, Christopher Barkley, Susan E Marino, Chao Wang, Sahng-Min Han, Angela K Birnbaum, Jean E Cibula, Mingzhou Ding

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical and experimental neuropsychology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Immanuel Babu Henry Samuela J. Crayton Pruitt Family Department of Biomedical Engineering , University of Florida , Gainesville , FL , USA.ORCID 0000-0001-7658-9454
Christopher Barkleyb Center for Clinical and Cognitive Neuropharmacology , University of Minnesota , Minneapolis , MN , USA.
Susan E Marinob Center for Clinical and Cognitive Neuropharmacology , University of Minnesota , Minneapolis , MN , USA.
Chao Wanga J. Crayton Pruitt Family Department of Biomedical Engineering , University of Florida , Gainesville , FL , USA.ORCID 0000-0002-1313-2569
Sahng-Min Hana J. Crayton Pruitt Family Department of Biomedical Engineering , University of Florida , Gainesville , FL , USA.
Angela K Birnbaumb Center for Clinical and Cognitive Neuropharmacology , University of Minnesota , Minneapolis , MN , USA.
Jean E Cibulac Department of Neurology , University of Florida , Gainesville , FL , USA.
Mingzhou Dinga J. Crayton Pruitt Family Department of Biomedical Engineering , University of Florida , Gainesville , FL , USA.

Funding

Characterizing and Predicting Drug Effects on CognitionR01NS076665 · NINDS · UNIVERSITY OF MINNESOTA · PI MARINO, SUSAN E · 2012 to 2016
$2.7M
NINDS NIH HHS R01 NS076665
6 · The paper itself

Abstract

introductionTopiramate (TPM), a frequently prescribed antiseizure medication, can cause severe cognitive side-effects. Though these side-effects have been studied behaviorally, the underlying neural mechanisms are unknown. In a double-blind, randomized, placebo-controlled, crossover study of TPM's impact on cognition, nine healthy volunteers completed three study sessions: a no-drug baseline session and two sessions during which they received either TPM or placebo. Electroencephalogram was recorded during each session while subjects performed a working-memory task with three memory-loads.

resultsComparing TPM with baseline we found the following results. (a) TPM administration led to declines in behavioral performance. (b) Fronto-central event-related potentials (ERP) elicited by probe stimuli, representing the primary task network activity, showed strong memory-load modulations at baseline, but the magnitude of these load-dependent modulations was significantly reduced during TPM session, suggesting drug-induced impairments of the primary task network. (c) ERP responses over bilateral fronto-temporal electrodes, which were not load sensitive at baseline, showed significant memory-load modulations after TPM administration, suggesting the drug-related recruitment of additional neural resources. (d) At fronto-central scalp sites, there was significant increase in response amplitude for low memory-load during TPM session compared to baseline, and the amplitude increase was dependent on TPM plasma concentration, suggesting that the primary task network became less efficient under TPM impact. (e) At bilateral fronto-temporal electrodes, there were no ERP differences when comparing low memory-load trials, but TPM administration led to an increase in ERP responses to high load, the magnitude of which was positively correlated with task performance, suggesting that the recruited neural resources were beneficial for task performance. Placebo-TPM comparison yielded similar effects albeit with generally reduced significance and effect sizes.

conclusionOur findings support the hypothesis that TPM impairs the primary task network by reducing its efficiency, which triggers compensatory recruitment of additional resources to maintain task performance.

Indexed as

AnticonvulsantsBrainCognitive DysfunctionCross-Over StudiesDouble-Blind MethodElectroencephalographyEvoked PotentialsFemaleHumansMaleMemoryNeuropsychological TestsPsychomotor PerformanceRecruitment, NeurophysiologicalTopiramateYoung AdultAnticonvulsantsTopiramateCognitioncompensationelectroencephalogramimpairmenttopiramate

Identifiers

PMID29720037
PMCPMC6141311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.